Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole plus Micafungin for Invasive Aspergillosis in Hematological Cancer
NCT01207128Phase 2Withdrawn
- Sponsor
- University of Arkansas
- Start
- Feb 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of micafungin in aspergillosis, sponsored by University of Arkansas. Planned start Feb 2011; status: withdrawn.
02
Drugs
micafungin
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NCT01207128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207128.